These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 27278163)

  • 21. Radiofrequency thermal ablation of hepatocellular carcinoma: using contrast-enhanced harmonic power doppler sonography to assess treatment outcome.
    Cioni D; Lencioni R; Rossi S; Garbagnati F; Donati F; Crocetti L; Bartolozzi C
    AJR Am J Roentgenol; 2001 Oct; 177(4):783-8. PubMed ID: 11566673
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Contrast-enhanced harmonic gray-scale sonographic-histologic correlation of the therapeutic effects of transcatheter arterial chemoembolization in patients with hepatocellular carcinoma.
    Morimoto M; Shirato K; Sugimori K; Kokawa A; Tomita N; Saito T; Imada T; Tanaka N; Nozawa A; Numata K; Tanaka K
    AJR Am J Roentgenol; 2003 Jul; 181(1):65-9. PubMed ID: 12818831
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Contrast-enhanced, wide-band, phase inversion harmonic power Doppler imaging of hepatocellular carcinoma.
    Janica J; Serwatka W; Polaków J; Kordecki K; Łebkowska U; Walecki J; Dobrzycki S
    Med Sci Monit; 2004 Jun; 10 Suppl 3():32-5. PubMed ID: 16538196
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The usefulness of 1.5 harmonic imaging ultrasonography with Levovist in the diagnosis of focal hepatic tumors.
    Yamamoto K; Shiraki K; Nakanishi S; Fuke H; Hashimoto A; Shimizu A; Nakano T
    Int J Oncol; 2005 Oct; 27(4):989-95. PubMed ID: 16142315
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of focal hepatic lesions in cirrhotic patients by Pulse Inversion Harmonic Imaging US contrast specific technique with Levovist.
    Quaia E; Forgács B; Calderan L; Bertolotto M; Pozzi Mucelli R
    Radiol Med; 2002 Oct; 104(4):285-94. PubMed ID: 12569309
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vascularity of hepatocellular carcinoma: assessment with contrast-enhanced second-harmonic versus conventional power Doppler US.
    Choi BI; Kim TK; Han JK; Kim AY; Seong CK; Park SJ
    Radiology; 2000 Feb; 214(2):381-6. PubMed ID: 10671584
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential diagnosis of hepatic tumors: value of contrast-enhanced harmonic sonography using the newly developed contrast agent, Sonazoid.
    Hatanaka K; Kudo M; Minami Y; Ueda T; Tatsumi C; Kitai S; Takahashi S; Inoue T; Hagiwara S; Chung H; Ueshima K; Maekawa K
    Intervirology; 2008; 51 Suppl 1():61-9. PubMed ID: 18544950
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of transcatheter arterial embolization therapy on hepatocellular carcinomas using contrast-enhanced harmonic power Doppler sonography: comparison with CT, power Doppler sonography, and dynamic MRI.
    Shima T; Mizuno M; Otsuji H; Mizuno C; Obata H; Park H; Nakajo S; Okanoue T
    J Med Ultrason (2001); 2005 Sep; 32(3):107-13. PubMed ID: 27277266
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detecting hepatocellular carcinoma: value of unenhanced or arterial phase CT imaging or both used in conjunction with conventional portal venous phase contrast-enhanced CT imaging.
    Oliver JH; Baron RL; Federle MP; Rockette HE
    AJR Am J Roentgenol; 1996 Jul; 167(1):71-7. PubMed ID: 8659425
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Contrast enhancement patterns of hepatic tumours during the vascular phase using coded harmonic imaging and Levovist to differentiate hepatocellular carcinoma from other focal lesions.
    Furuse J; Nagase M; Ishii H; Yoshino M
    Br J Radiol; 2003 Jun; 76(906):385-92. PubMed ID: 12814924
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of hepatocellular carcinoma: comparison of dynamic MR imaging with dynamic double arterial phase helical CT.
    Noguchi Y; Murakami T; Kim T; Hori M; Osuga K; Kawata S; Kumano S; Okada A; Sugiura T; Nakamura H
    AJR Am J Roentgenol; 2003 Feb; 180(2):455-60. PubMed ID: 12540451
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Perfusion MR imaging with a superparamagnetic iron oxide using T2-weighted and susceptibility-sensitive echoplanar sequences: evaluation of tumor vascularity in hepatocellular carcinoma.
    Ichikawa T; Arbab AS; Araki T; Touyama K; Haradome H; Hachiya J; Yamaguchi M; Kumagai H; Aoki S
    AJR Am J Roentgenol; 1999 Jul; 173(1):207-13. PubMed ID: 10397128
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatocellular carcinoma treated with radiofrequency ablation: comparison of pulse inversion contrast-enhanced harmonic sonography, contrast-enhanced power Doppler sonography, and helical CT.
    Meloni MF; Goldberg SN; Livraghi T; Calliada F; Ricci P; Rossi M; Pallavicini D; Campani R
    AJR Am J Roentgenol; 2001 Aug; 177(2):375-80. PubMed ID: 11461867
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Contrast-enhanced power Doppler sonography and helical computed tomography for assessment of vascularity of small hepatocellular carcinomas before and after percutaneous ablation.
    Vilana R; Llovet JM; Bianchi L; Sanchez M; Pagés M; Sala M; Gilabert R; Nicolau C; Garcia A; Ayuso C; Bruix J; Bru C;
    J Clin Ultrasound; 2003; 31(3):119-28. PubMed ID: 12594796
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes in tumor vascularity precede microbubble contrast accumulation deficit in the process of dedifferentiation of hepatocellular carcinoma.
    Maruyama H; Takahashi M; Ishibashi H; Okabe S; Yoshikawa M; Yokosuka O
    Eur J Radiol; 2010 Jul; 75(1):e102-6. PubMed ID: 19783392
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Contrast-enhanced sonography for the characterisation of hepatocellular carcinomas--correlation with histological differentiation.
    Strobel D; Kleinecke C; Hänsler J; Frieser M; Händl T; Hahn EG; Bernatik T
    Ultraschall Med; 2005 Aug; 26(4):270-6. PubMed ID: 16123920
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Qualitative diagnosis of hepatocellular carcinoma by contrast enhanced ultrasonography using Coded Harmonic Angio with Levovist.
    Hirai T; Ohishi H; Tokuno E; Takahashi M; Sakaguchi H; Anai H; Nishimoto Y; Hirohashi S; Kichikawa K
    J Med Ultrason (2001); 2002 Mar; 29(1):3-9. PubMed ID: 27277589
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical utility of doppler ultrasonography in evaluation of early therapeutic efficacy after transcatheter arterial embolization in patients with hepatocellular carcinoma.
    Hibi T; Kumada T; Takeshima K; Ito M; Noda T; Goto S; Sugita F; Sassa T; Ichikawa H; Nakano S
    J Med Ultrason (2001); 2002 Jun; 29(2):47. PubMed ID: 27277740
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vascularization and perfusion of hepatocellular carcinoma: assessment with contrast-enhanced ultrasound using perflutren protein-type A microspheres.
    Jung EM; Kubale R; Jungius KP
    Clin Hemorheol Microcirc; 2005; 33(1):63-73. PubMed ID: 16037634
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Color Doppler sonography of hepatic tumors with a galactose-based contrast agent: correlation with angiographic findings.
    Fujimoto M; Moriyasu F; Nishikawa K; Nada T; Okuma M
    AJR Am J Roentgenol; 1994 Nov; 163(5):1099-104. PubMed ID: 7976882
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.